The Muscular Dystrophy Association (MDA) proudly announces that its groundbreaking MDA Kickstart program has received both an FDA Rare Pediatric Disease designation and Orphan Drug Designation for ...
Researchers at Tufts University School of Medicine and the Graduate School of Biomedical Sciences (GSBS) have identified a ...
We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
At #STATSummit, three parents discussed the challenges they've faced trying to find treatments for their children with rare ...
Carrie Jean Robinette, 46, of San Diego, has always had a lot of health issues, but she didn’t think she had a serious ...
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a clinical ...
(MENAFN- GlobeNewsWire - Nasdaq) NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October ...
Register to read this story and more for free. Signing up for an account helps us improve your browsing experience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback